These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29741594)

  • 1. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.
    Koss CA; Ayieko J; Mwangwa F; Owaraganise A; Kwarisiima D; Balzer LB; Plenty A; Sang N; Kabami J; Ruel TD; Black D; Camlin CS; Cohen CR; Bukusi EA; Clark TD; Charlebois ED; Petersen ML; Kamya MR; Havlir DV;
    Clin Infect Dis; 2018 Nov; 67(12):1853-1860. PubMed ID: 29741594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda.
    Mayer CM; Owaraganise A; Kabami J; Kwarisiima D; Koss CA; Charlebois ED; Kamya MR; Petersen ML; Havlir DV; Jewell BL
    J Int AIDS Soc; 2019 Apr; 22(4):e25276. PubMed ID: 31037845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
    Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
    AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda.
    Ayieko J; Petersen ML; Kabami J; Mwangwa F; Opel F; Nyabuti M; Charlebois ED; Peng J; Koss CA; Balzer LB; Chamie G; Bukusi EA; Kamya MR; Havlir DV
    J Int AIDS Soc; 2021 Jun; 24(6):e25670. PubMed ID: 34152067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial.
    Kakande ER; Ayieko J; Sunday H; Biira E; Nyabuti M; Agengo G; Kabami J; Aoko C; Atuhaire HN; Sang N; Owaranganise A; Litunya J; Mugoma EW; Chamie G; Peng J; Schrom J; Bacon MC; Kamya MR; Havlir DV; Petersen ML; Balzer LB;
    J Int AIDS Soc; 2023 Dec; 26(12):e26195. PubMed ID: 38054535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study.
    Kabami J; Kakande E; Chamie G; Balzer LB; Petersen ML; Camlin CS; Nyabuti M; Koss CA; Bukusi EA; Kamya MR; Havlir DV; Ayieko J
    J Int AIDS Soc; 2023 Jul; 26 Suppl 1(Suppl 1):e26121. PubMed ID: 37408473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.
    Pyra M; Haberer JE; Heffron R; Kidoguchi L; Brown ER; Bukusi EA; Asiimwe S; Celum C; Katabira E; Mugo NR; Baeten JM;
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):41-45. PubMed ID: 29016523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum.
    Bhatia R; Modali L; Lowther M; Glick N; Bell M; Rowan S; Keglovitz K; Schneider J
    Sex Transm Dis; 2018 Jan; 45(1):50-55. PubMed ID: 28876282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.
    Nyabuti MN; Petersen ML; Bukusi EA; Kamya MR; Mwangwa F; Kabami J; Sang N; Charlebois ED; Balzer LB; Schwab JD; Camlin CS; Black D; Clark TD; Chamie G; Havlir DV; Ayieko J
    PLoS One; 2021; 16(2):e0243167. PubMed ID: 33544717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda.
    Christian C; Kabami J; Kwarisiima D; Beinamatsiko B; Nakato H; Khakshi JW; Sulaiman M; Komugisha A; Thirumurthy H; Havlir DV; Kamya MR; Chamie G
    AIDS Care; 2023 Jan; 35(1):41-47. PubMed ID: 36473203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.